Active substances: Clomiphene
After grouping the stimulated cycles for reproductive outcomes, perifollicular vascularization alone ended up being significantly lower only in CC-stimulated cycles with unfavorable outcome. Do you want to read the rest of this article?
Request full-text Citations 32 References 46... The endometrial pattern was studied in periovulatory and mid- luteal phases and subjectively evaluated by the comparison with the echogenicity of the surrounding myometrium. Ascending main branches of the uterine arteries on both sides of the cervico-uterine junction, at the level of the internal os in a longitudinal plane, and before entering the uterus were visualized using a colour Doppler system.
Uterine flow was studied by positioning a sample volume over the area of maximum colour intensity and by activating the pulsed Doppler. Using a power Doppler system, subendometrial and endometrial blood flows were visualized. Doppler flow indices were studied at random on the subendometrial and endometrial areas with maximum colour intensity; the lowest values concerning flow resistance were recorded.
For each examination, the resistance index RI was calculated electronically by the machine on three consecut- ive waveforms of good quality and used as an angle-independent index of blood flow impedance.
For each patient, images with colour signals from uterine fundus to the cervico-uterine junction at the level of the internal os in a longitu- dinal plane were recorded and then acquired using an advanced dig- ital camera and processed.
Successively, the extension of vascularity was studied by use of advanced image analysis software Image-Pro Plus 4.
Specifi- cally, an operator not aware of who the images belongs to, calculated the extension of vascularity as a ratio between areas in which blood flows were detected identified as coloured areas by use of the power Doppler and the total selected subendometrial and endometrial areas.
Some women using this medicine develop a condition called ovarian hyperstimulation syndrome OHSS, especially after the first treatment.
OHSS can be a life threatening condition. Call your doctor right away if you have any of the following symptoms of OHSS: stomach pain, bloating; rapid weight gain, especially in your face and midsection; little or no urinating; or pain when you breathe, rapid heart rate, feeling short of breath especially when lying down.
Stop using Clomid and call your doctor at once if you have: pelvic pain or pressure, enlargement in your pelvic area; vision problems; seeing flashes of light or "floaters" in your vision; increased sensitivity of your eyes to light; or heavy vaginal bleeding.
Call your doctor for medical advice about side effects.
See also: Clomid side effects in more detail Clomid dosing information Usual Adult Dose for Ovulation Induction: 50 mg orally once a day for 5 days. Most patients ovulate following the first course of therapy.
Usual Adult Dose for Lactation Suppression: 50 to 100 mg orally once a day for 5 days.